Live · Auto-synced from daily commentary · Updated each morning
Capital Wealth — Watchlist & Recent Changes
The active book. What's coming in. What's coming out.
Two views of the same workflow. The Watchlist is auto-synced from every commentary page — every "ADD," "REINFORCE," and "TRIM" call we publish ends up here within minutes. The Recent Changes section is the most recent day's specific moves, with thesis paragraphs.
Watchlist — live feed
🔒 Full Dividend Holdings — Client Access
See all dividend & income positions across Conservative, Moderate, and Aggressive allocations
Incorrect code
Watchlist — Auto-Synced from Daily Commentary
Live feed of ticker recommendations pulled from every commentary page. Updated automatically on page load.
Auto-Sync Feed
Recommendations from Commentary
Loading…
Ticker
Company
Sector
Action
Thesis
Source
Fetching commentary pages…
Rows are aggregated from #cw-watchlist-sync blocks on each commentary page. Latest commentary first.
Static Conviction Portfolio — April 17, 2026
Tier 1 (Core Holdings) | Tier 2 (Satellite Bets)
TIER 1 — Core Holdings
#
Ticker
Company
Sector
YTD %
Thesis
1
XOM
ExxonMobil
Energy
+27.6%
Blockade beneficiary. Largest US major. Strong cash generation.
2
CVX
Chevron
Energy
+22.0%
#2 US major. Dividend + buyback machine.
3
NVDA
NVIDIA
AI Semis
+35.7%
AI chip monopoly. Data center demand surging.
4
CRWD
CrowdStrike
Cyber
+18.0%
Tier 1 elevation. ARR $5.25B. AI-driven breakout.
5
SNOW
Snowflake
AI/Data
+22.0%
AI data platform. Revenue +26% YoY. NEW.
6
GEV
GE Vernova
Power/Grid
+29.2%
Power grid + renewables spin-off. Structural demand.
7
LMT
Lockheed Martin
Defense
+28.0%
Stealth missiles. NATO demand accelerating.
8
IAU
iShares Gold
Hedge
+24.0%
Gold ATH $4,742. Central banks buying. Diversifier.
9
JPM
JPMorgan
Bank
+4.0%
Q1 beat. Trading revenue surging. Anti-recession.
10
GS
Goldman Sachs
Bank
+8.0%
Record equities trading $4.2B. M&A recovery.
11
AA
Alcoa
Aluminum
+15.0%
EV + aerospace demand. Supply constraint play.
12
VRT
Vertiv
DC Infra
+22.0%
Data center power + cooling. AI buildout tailwind.
TIER 2 — Satellite Bets
#
Ticker
Company
Sector
YTD %
Thesis
13
COP
ConocoPhillips
Energy E&P
+20.0%
Pure-play E&P. High leverage to oil prices.
14
LNG
Cheniere Energy
LNG Export
+25.0%
#1 US LNG exporter. Europe demand surging.
15
PLTR
Palantir
Defense Tech
+76.0%
Defense AI + data. Biggest gainer YTD.
16
MDB
MongoDB
AI/Database
+18.0%
AI database leader. $2.35B FY26 rev. NEW.
17
ZS
Zscaler
Cyber
-8.0%
Zero trust. Depressed valuation = value. $240B cyber market. NEW.
AWS +37% at a 39% margin — the cloud is where AI money becomes profit.
⬆️
MSFT
REINFORCE
Growth / AI toll booth
Largest one-day market-cap gain ever; Azure +43%.
⬆️
LLY
REINFORCE
Growth sleeve
Mounjaro +91%; CVS transparent-pricing tie-up widens the GLP-1 moat.
⬆️
CAT
REINFORCE
Industrial / AI power
First $20B quarter ever; sells the workaround to the grid bottleneck.
⬆️
CVX · XOM
REINFORCE
Energy hedge
Record quarters; refiners at 97% utilization; crude stocks at 42-year lows.
👀
PFE
REVIEW
Midterm $500K tier
The Dividend Mind Trick name: 6.9% yield eating nearly all free cash flow. Coverage review open.
👀
VST · NRG
WATCH
Power / AI grid
Texas interconnection audit: right decade, wrong month.
🎯
SGOV
THESIS
Every book
4%-plus seatbelt while the AI boom debt-finances itself at a 230% Buffett Indicator.
Recent Changes — July 31, 2026
The Week in Review (Thu Jul 30 · Fri Jul 31 papers). REINFORCE: PM, CVX, XOM, GD, RTX, LMT, MSFT, V, SGOV, XLU, LLY, REGN. ADD: AMGN (starter). HOLD: NVDA, META, JNJ, KO, BA, PG, MO, BTI, TSM, NVO. WATCH: MU, HOOD, UAL, DAL, HUM, MS, QCOM. AVOID: TLT/long duration, tanker-refiner momentum, pre-revenue obesity biotech. THESIS: the Fed held 3.50%–3.75% on a 9–3 vote with three same-direction hike dissents — the first since 2016 — and the Dow paid 1,153 points to learn the difference between rates on hold and help on the way; oil ran $89.31 to $79.26 to $84.46 in five sessions on a war-set floor while Heard on the Street showed China cutting crude imports roughly 40% during the Hormuz closure — "China is the OPEC of oil demand" — so the floor is geopolitical and the ceiling is Chinese; the Pentagon put more than $120 billion behind a Patriot-and-submarine restock; and the AI trade split into receipts (MSFT) and invoices (META, and a $12.55 billion bond at 7.5%). GLP-1 is a franchise war with a winner (LLY +14.3% vs NVO −2.2%) and a payer problem — Part D premiums are rising because of these drugs, with 45% of enrollees facing $11 to $20 a month more. Own the leader, the adjacency (REGN muscle-preservation) and the cheap option (AMGN). Do not pay for the tail. The tracker moved; the books did not rebalance — that waits for the monthly date or a ±trigger.
Action
Change
Rationale
⬆️ REINFORCE
PM — the sleeve got a factory
Philip Morris International opened a $1.2 billion, 780,000-square-foot Zyn campus in Aurora, Colorado — doubled from its original $600 million budget, with $200 million more already committed. Nine days after the tobacco sleeve went into the income books, the company printed the capex receipt. Capital spending of that size is not a marketing plan; it is a company telling you where the volume is going for the next decade. The sleeve stays small and stays excluded wherever a mandate says no — that part does not change.
⬆️ REINFORCE
CVX · XOM — war-floored, China-ceilinged
WTI ran $89.31 to $79.26 to $84.46 in five sessions on nothing but the war turning its head, and the energy sleeve was the only green on the day the Dow lost 1,153 points. Heard on the Street then supplied the other side of the trade: China cut crude imports roughly 40% during the Hormuz closure — 11.6 million barrels a day down to about seven million. The floor is geopolitical and it held; the ceiling is softer than the old playbook assumed. Sleeve weight is insurance, never a bet, and there are no adds on strength.
⬆️ REINFORCE
GD · RTX · LMT — the $120 billion restock
The Pentagon earmarked more than $120 billion for Patriot missiles and submarines, including a $59 billion Lockheed contract and a $76.6 billion submarine deal — and General Dynamics beat on every segment. This is an appropriations floor, not a cycle: the interceptors fired over Jordan this week have to be replaced whatever happens next in the diplomacy. We own the complex, not a single fuselage or a single missile.
⬆️ REINFORCE
MSFT · V — receipts, not invoices
The AI trade split in public this week. Microsoft showed cloud revenue that customers actually paid for; Meta showed a $12.55 billion data-center bond priced at 7.5%. One side is collecting, the other is borrowing. Visa is the same shape one floor down: revenue up 17%, U.S. payments volume up 8%, outlook raised — the rails get paid whether the cardholder is thriving or rationing. Own the toll, not the traffic.
⬆️ REINFORCE
SGOV · XLU — paid while they argue
The Fed held at 3.50%–3.75% on a 9–3 vote with all three dissents pointing up — the first triple same-direction dissent since 2016 — and the chair offered "no magic wand." Inflation has run above target five years running. When the argument inside the building is about hikes, the short end is not a parking space, it is a position. Bills at 4%-plus and regulated utility cash flows are how the book gets paid for having no opinion on the outcome.
⬆️ REINFORCE
LLY · REGN — the franchise and the side effect
Roughly 13 million Americans are on GLP-1s, per JPMorgan research published in February, and our own books have already graded the franchise war: Eli Lilly +14.3% against Novo Nordisk −2.2% this year. Same drug class, same calendar, sixteen points apart. Lilly gets the reinforce — tactical-tier weights toward the Income & Quality treatment where the risk budget allows, funded from cash and index, never from a conviction holding. Regeneron gets the second leg for a different reason: patients on these drugs lose significant muscle along with fat, a particular risk for older adults who need the strength to stay independent, and Regeneron is developing muscle-preservation therapies to pair with the weight-loss medications plus a DNA-derived obesity program. It is not a GLP-1 stock. It is the bet that the side effect becomes its own market.
🆕 ADD
AMGN — the cheap option, sized small
Already on the July 17 reinforce list, so this is a weight decision rather than a new relationship. Amgen holds an obesity program with a differentiated dosing profile, trades at a fraction of the franchise multiple, and pays a dividend that makes the wait tolerable. Started small on purpose: this is the option, not the position. If the category consolidates around one or two winners, a starter position is what you want to have owned; if it does not, the dividend was the rent.
👀 HOLD
NVDA · META — the boom is financing itself
Nvidia is in talks to backstop roughly $250 billion of OpenAI’s data-center financing on a project that could exceed $500 billion. Vendor financing is how a supplier keeps demand alive when the customer cannot fund it alone — profitable for a while, and a well-documented way for a cycle to end. AI-related bond supply hit $270 billion by early July, nearly double all of 2025. Held at weight in both names; nothing added into a chip trade that has started lending to its own customers.
👀 HOLD
JNJ · KO · PG · MO · BTI — the ballast, and its bill
Procter & Gamble guided to a $1 billion after-tax hit from war-related costs, with guidance assuming Brent near $90. That is not a flaw in the book; that is the pairing working. The staple pays $90 Brent so the major on the other page collects it, and the client owns both sides of the invoice. Coca-Cola raised guidance on the World Cup. Hold the defensives at weight; the number to watch at P&G is volume, not oil.
👀 HOLD
BA · TSM — backlogs beat headlines
Washington put as much as $3 billion of Ex-Im loans and guarantees behind JetZero’s blended-wing aircraft, which makes Boeing’s American monopoly a policy question rather than a fact — but certification is a decade and tens of billions away, and it does not dent a seven-year backlog. TSM stays index-shaped through a week when the memory complex reminded everyone that bottlenecks attract profits first and rivals second.
👀 HOLD
NVO — kept for the job it was hired to do
Down 2.2% on the year while the franchise leader is up 14.3%, and yet not a sale. Novo Nordisk holds the Denmark and developed-market diversification slot in the global sleeves, and selling the losing half of a pair into a franchise war is how you lock in the wrong half. It gets no new dollars. The competition line from the Regeneron profile — dozens of companies racing to launch their own versions of GLP-1 drugs, with Chinese biotechs moving quickly to replicate successful science — lands hardest on the pure-play that is already losing share.
👀 WATCH
MU · QCOM — the memory canary
SK Hynix reported a record $64 billion quarterly profit — thirteen times a year earlier, more than its previous five years combined — and the stock fell nearly 10%, dragging Micron with it. Qualcomm blamed part of its own weak quarter on higher memory costs. When perfect earnings get sold and the customer layer starts bleeding on input prices, the market is grading the durability of the boom, not the quarter. MU stays on the watch opened in Part I; QCOM joins it as the canary.
👀 WATCH
UAL · DAL — the approach was the tell
United approached Delta last year about a merger that would have combined the two most valuable U.S. carriers. Nothing came of it, and the antitrust math says nothing was ever going to. The signal is not the deal; it is that the strongest operator in a cyclical industry went looking for scale rather than growth. Late-cycle behavior, filed and watched. No position change.
👀 WATCH
HUM · MS · HOOD — three different kinds of policy risk
The administration will end a program handing Part D insurers an estimated $3.6 billion this year, and roughly 25 million people learn their 2027 rates this fall — a margin question for the Medicare Advantage complex. Inside Morgan Stanley’s private bank, an employee who questioned repeated owner-occupied mortgage approvals was told to drop it; governance stories are slow and then sudden. And the prediction-market fight over the midterms is now headed for the Supreme Court, which is the whole HOOD thesis in one sentence. All three watched, none owned on the story.
⛔ AVOID
TLT · long duration — nobody is coming
Three dissents pointing up, inflation above target for a fifth straight year, and a ten-year that sat at 4.621% through a war, a tariff round and a Fed argument. Five months of our own market put the long rate in a narrow band around 4.6% and going nowhere. Duration is a bet on rescue. No rescue is being offered, and the short end pays you to wait for one.
⛔ AVOID
Tanker & refiner momentum — the wrong end of the hedge
The temptation in a week like this is to chase the leveraged version of a thesis that just worked. We do not. If the biggest buyer on Earth can flex demand 40% at will, rallies get sold faster and high prices carry their own cure — and the vehicles that need the price to keep rising are exactly the ones that do not survive the reversal. The hedge is owned at sleeve weight in the majors, and that is the whole position.
⛔ AVOID
Pre-revenue obesity biotech — a crowded lottery
No pure-play, pre-revenue obesity name, and nothing whose entire case is "the next GLP-1." An industry founder has said out loud that dozens of companies are building their own versions and that Chinese replication is a threat to the whole industry; that is where the losses in this theme will live. The payer is the risk we are actually underwriting: Part D premiums are rising because of these drugs, 45% of enrollees face $11 to $20 a month more, and KFF expects the pressure to run into 2027 — which argues for the leader with a pipeline, the adjacency and the cheap option, and against paying up for volume a formulary committee can reprice.
Recent Changes — July 17, 2026
The Reckoning (Thu Jul 17 paper). REINFORCE: UBER, MRK, AMGN, REGN, KO, PG, CLX, CVX, XOM, COP, SGOV. HOLD: GOOGL, AVGO, TSM, MU, UNH. WATCH: INTC, AAPL, ABB, LLY, AIZ, AIG, NEE, MOS, CF. AVOID: IBM, DLVY (until close), NKE, MCD. THESIS: IBM warned before the open and fell 25% in a session — the worst day in the company’s 112-year history — and the AI trade split publicly into silicon (fine) and slideware (repricing); Uber bought Delivery Hero for $14.8 billion in stock, which is a graduation ceremony for a former cash bonfire; Merck’s Lipfendra became the first oral PCSK9 with $5B+ peak sales penciled in; and June retail sales grew 0.2%, half May’s pace — the consumer is rationing, and the books already own the must-pays. The tracker moved; the books did not rebalance — that waits for the monthly date or a ±trigger.
Action
Change
Rationale
⬆️ REINFORCE
UBER — the knife fight becomes a toll road
Uber agreed to buy Delivery Hero for $14.8 billion, all stock — a combined footprint of 70-plus countries, with Delivery Hero holders taking ~5% of the merged company. The currency is the story: a business that spent its adolescence burning investor money can now hand over its own equity for the number-two player on Earth and have the conversation be about integration, not solvency. Density is the entire economics of delivery; a decade of paying twice for the same corner just ended. DLVY itself stays untouched until close — merger arbitrage is a profession, and it isn’t ours.
⬆️ REINFORCE
MRK · AMGN · REGN — the category, not the horse race
The FDA approved Merck’s Lipfendra, the first oral PCSK9 inhibitor — roughly 60% LDL reduction versus 20–30% for statins, with $5 billion-plus peak annual sales penciled in. A first-in-class oral in a proven category is the cheapest kind of blockbuster: science validated, market already there, and the only innovation the patient notices is that nothing gets injected. A lipid market this size feeds three winners rather than crowning one — Amgen’s Repatha and Regeneron’s Praluent stay held on their own merits.
⬆️ REINFORCE
KO · PG · CLX — the must-pay economy
June retail sales grew 0.2% — half of May’s 1.0%, below the 0.4% forecast, with apparel and furniture doing the damage. A consumer growing at 0.2% is a consumer rationing, and rationing is where discretionary earnings estimates go to die. People economize toward staples, not away from them. Same-day proof of the sort: UnitedHealth beat and raised while IBM fell down the stairs. Health premiums and household staples get paid; consulting engagements and couches wait.
👀 HOLD
GOOGL — paperwork is not a moat-drain
Brussels handed Alphabet a binding Digital Markets Act order to open Android and Search data to competitors, with 60 days to propose compliance. The stock dipped and shrugged — the market has seen this movie. A moat that can be drained by a compliance filing was never a moat; Google’s is scale, habit, and eleven billion daily acts of muscle memory. We watch whether “open the data” produces a competitor or a compliance department. History bets on the compliance department.
👀 WATCH
ABB · LLY — the consolidation weather
Third and fourth consolidation headlines in one week’s Journal: ABB buying Britain’s Rotork for $5.6 billion in industrial automation, Eli Lilly paying $2.8 billion for mental-health developer AtaiBeckley. When growth gets scarce and money has a real cost, companies stop planting and start harvesting each other. Late-cycle consolidation favors scale, balance sheets, and boring integration skill — which is how the books are already built. Both on watch for the numbers to validate the deals.
⛔ AVOID
IBM — cheap the way a flooded car is cheap
A pre-market warning — consulting demand soft, AI roadmap foggy — and the stock fell 25% by the close, the worst single day in 112 years of trading. A stock that can reprice that much on one phone call is a stock where insiders and shareholders were reading two different books. The markdown tells you the price changed, not that the problem is fixed. Re-entry test: two consecutive quarters of stabilized consulting billings. Not a press release. Not a roadmap with better fonts. The silicon half of the AI trade (AVGO, TSM, MU) is unchanged and unbothered.
⛔ AVOID
NKE · MCD — the can-wait economy
Apparel led June’s retail weakness, and a rationing consumer postpones the swoosh and skips the drive-through more often than the headline suggests. Benched until consumption reaccelerates — not a call on the brands, a call on the wallet.
Recent Changes — July 11–14, 2026
The Mid-Week Review (Sat Jul 11 · Mon Jul 13 · Tue Jul 14 papers). ADD: HWM, XLV. REINFORCE: JPM. HOLD: GLD, NVDA. WATCH: KVUE. AVOID: DAL. THESIS: the question flipped from “how many cuts” to “how many hikes” — futures went from 18% to 42% odds of a rise this month and 56% on two by year-end, so stop planning around cuts and get paid on the short end; fighting resumed and WTI jumped 9.42% in one session to $78.14 with Hormuz traffic down to 19 ships a day and the reserve at a 1983 low — the energy insurance stays on, but Goldman sees new pipelines routing around the strait by 2027; and gold fell 2.6% on the exact headline it hedges, which is an argument for a written target percentage, not for a view. The tracker moved; the books did not rebalance — that waits for the monthly date or a ±trigger.
Action
Change
Rationale
🆕 ADD
HWM — the AI build-out without the chip multiple
Every AI data center needs power, and power needs turbines. Howmet says its share of the global gas-turbine market is over 50% and expects that revenue to double in three to five years; Q1 gas-turbine revenue rose 39%. The tell is spare parts — now about 23% of revenue, up from 11% in 2019, because installed turbines are being run harder than anyone planned. Backlogs for heavy-duty power turbines run as long as eight years. Unlike a chip order, the customer can’t cancel and get those years back.
🆕 ADD
XLV — the sleeve nobody has bid up
Health care has badly lagged the Nasdaq for three straight years, which is the entire reason to look now. Goldman Sachs puts the present value of AI’s benefit to drug development at as much as $400 billion over the next decade. The honest timeline sits in the same article: only about 1 in 10 candidates entering human trials reaches the market, and the industry is described as in the “second inning.” Bought as a defensive holding for what it does in a drawdown — any AI-drug upside is free.
⬆️ REINFORCE
JPM — the only sector that worked
Monday was the whole argument: the S&P 500 fell 0.79% and its tech sector fell 2.07%, while financials rose 0.61% — the only sector green on a day when stocks, bonds and gold all fell together. The mechanism is plain: a Fed that may raise rather than cut keeps bank margins wide, and futures now put 42% on a hike this month. JPM reported Tuesday alongside GS, BAC, WFC and C, so the margin story gets marked to market fast.
👀 HOLD
GLD · NVDA — held, not chased
Gold is ~25% below January’s $5,318 record and fell 2.6% Monday on the very news it hedges — a reason to hold to a stated percentage, not to add on the dip or dump on the drop. The 76-year-old retired adviser in Tuesday’s paper has held roughly 3% since 2008 and did nothing. Say the mechanical part out loud: gold pays no interest while the two-year pays 4.261%. On NVDA: it fell 3.5% as the semis index dropped 4.78% in a session, yet nearly every client already owns a large position through index funds without choosing it — and after a $25B June bond sale, its debt too. Nothing to add; the work is measuring what’s already there.
👀 WATCH
KVUE — the docket, not the dividend
The Second Circuit revived more than 500 lawsuits alleging Tylenol and generic acetaminophen can cause ADHD or autism if taken during pregnancy, ruling the trial judge wrongly excluded the plaintiffs’ experts. No link has been proven, and acetaminophen remains what the major medical groups recommend in pregnancy. But Kimberly-Clark has agreed to buy Kenvue for more than $40 billion, and that deal now carries the litigation with it. Courtrooms, not earnings, set the price here. No add until the path is visible.
⛔ AVOID
DAL — someone else sets your biggest input cost
Delta’s Q2 revenue jumped 19% to $19.76 billion on just 1% more capacity — and profit still fell, to $1.6 billion from $2.13 billion. One line explains it: fuel averaged $3.66 a gallon against $2.21, the highest quarterly fuel bill in the airline’s history, and the CEO said fare increases covered only 60% of the fuel-cost increase. That was reported Saturday, when oil sat at $71.41. On Monday oil went up another 9.42%. Strong demand is not the same as a good investment.
Recent Changes — July 9–10, 2026
Two Dailies (The Hike Issue · The Peace Trade Issue). REINFORCE: MU, AVGO, BA, CVX, XOM, SGOV. WATCH: MPC, VLO, SPCX, BTI, PEP, COST, NFLX, CRM, SK Hynix debut. AVOID-class: PARA/WBD leverage, CNC/ELV policy risk. THESIS: the first Warsh-era minutes put hikes on the table (9 of 18 dots, 80%+ futures odds by December) — stay short-duration and get paid while they argue; Hormuz traffic “essentially stopped” and the SPR sits at a 1983 low — the energy insurance stays on; the AI trade rotated from hyperscalers into suppliers (semis +83% YTD, MU’s $250B U.S. plan, Apple’s $30B Broadcom commitment) — own the sleeve, not the horse.
Action
Change
Rationale
⬆️ REINFORCE
MU · AVGO — AI suppliers
Micron +4.5% on a $250B U.S. manufacturing investment as the rotation moved from hyperscalers to hardware (SNDK, WDC, ON, MRVL, AMD led; NVDA/GOOGL/MSFT lagged). Apple committed $30B+ over five years to Broadcom RF chips built in Fort Collins — signed, underwritable supplier revenue. Memory is the build-out’s tightest bottleneck; MU upgraded from watch.
⬆️ REINFORCE
BA — Boeing catalyst
FAA expected to certify the 737 MAX 7 as soon as late July and restore Boeing’s final safety sign-off authority — a dated catalyst that converts a parked backlog into deliveries and cash. Southwest (LUV) the direct beneficiary. Sized like the turnaround it still is.
⬆️ REINFORCE
CVX · XOM — energy sleeve · SGOV — short Treasuries
Hormuz tanker traffic “essentially stopped” (Rystad); WTI +4.4% Wednesday on a day inventories actually rose — a pure risk-premium bid — then eased 2% on peace signals with the SPR at its lowest since 1983, diesel at two-decade lows and gasoline $3.85 vs $2.98 prewar. Thin buffers amplify the next shock. On rates: 9 of 18 dots see hikes, prediction markets put 78% on zero cuts in 2026 — bills keep paying 4%+.
👀 WATCH
MPC · VLO — refiners · SK Hynix — U.S. debut · BTI — income candidate
Marathon and Valero hit 52-week highs on the Kremlin’s diesel-export ban (diesel +72% YTD) — we don’t chase war-headline highs; on the bench for a pullback. SK Hynix’s $28B Nasdaq listing starts Friday at ~6x forward earnings — cheap if the memory cycle holds, a trap if it doesn’t. British American Tobacco doubled in two years on the smoke-free re-rating (U.S. pouch share 6.7%→16.2%) — income-book candidate, mandate rules apply.
👀 WATCH
PEP · COST — staples check · NFLX · CRM — disruption bill
PepsiCo beat ($2.20 adj EPS) and fell 3.3% — $3.85 gasoline is squeezing traffic-to-purchase conversion; Costco grew June sales 10.6% (from 13.7%) and fell 4.2% — priced for perfection. Holdings unchanged, consumer stress noted. Netflix’s viewing share hit a 14-month low (7.8%); Salesforce downgraded on “Agentforce just isn’t there” — the AI bill is coming for legacy engagement and legacy SaaS alike.
⛔ AVOID
PARA/WBD — leverage · CNC/ELV — policy risk
Paramount–Warner closes with ~$80B net debt at 6.5x EBITDA against TV revenue shrinking ~10%/yr; the long bonds already pay 8.43% — credit’s honest opinion of the synergy slideware. Managed care is asking for 28% ACA increases into a shrinking, sicker pool with an election cycle ahead — policy risk in both directions. Turnarounds get bought after the cash flow shows up.
Recent Changes — July 7–8, 2026
Two Dailies (The Fever Issue · The Blink Issue). REINFORCE: CVX, XOM, LMT, RTX, SGOV, IAU, JPM. WATCH: PNC (dividend +18%), NVDA, MU, META, SPCX, SHEL, RIVN, MSFT, FI, TM, DAL. AVOID-class: MSTR, evergreen PE wrappers. THESIS: the AI capex war hit $710B/yr and chips slid 11% in two days on Meta’s rent-out-the-compute hint — own the tollbooths (energy, defense, dividends, T-bills), not the arms race; the U.S. revoked Iran’s oil license (WTI $70.44) and the energy sleeve earned its premium; Korea’s memory mania (Samsung profit 19x, Kospi +91% YTD) is real cycle + rented conviction — own via indexes, never 2x wrappers.
Action
Change
Rationale
⬆️ REINFORCE
CVX · XOM — energy sleeve
U.S. struck 80+ Iranian targets and revoked the June 21 oil-sale license (grace to Jul 17); WTI +$1.89 to $70.44, Brent near $76. ~20% of world oil still transits Hormuz at 30–60 crossings/day. The insurance sleeve pays a dividend while it waits — and works on exactly these mornings.
⬆️ REINFORCE
LMT · RTX — defense sleeve
Nine NATO nations launched the DSRB “defense bank” in Ankara; Raytheon will build AMRAAM components in Europe for the first time; Lockheed–Rheinmetall to produce Atacms in Germany. Rearmament is a multi-year funded backlog, not a headline.
⬆️ REINFORCE
SGOV — short Treasuries · IAU — gold · JPM — financials
June FOMC minutes land with the target at 3.50–3.75% — bills keep paying 4%+ while the committee argues. Gold +$42.40 to $4,155 on a record-Dow day (the no-forecast hedge). KBW banks +1.88% and four giants circle Fiserv’s debit network for the Durbin exemption — the fee-plumbing moat.
👀 WATCH
PNC — dividend raise · NVDA/MU/META — the AI flinch · SPCX — index debut
PNC raised its quarterly payout to $2.00 from $1.70 (+18%) a week after the stress tests — income-book evidence, evaluating for the dividend models. PHLX semis −11% in two days (MU −15%, SK Hynix −17%, CAT −10%) after Meta — 20GW installed, 14 coming, FCF going negative — said renting out compute “is an option.” SpaceX fell 6.8% to $149.47 on Nasdaq-100 inclusion day as ~$800B of index money became obligated buyers; 2036 bond spreads widened 1.4→1.65.
👀 WATCH
MSFT · FI · TM · DAL · SHEL · RIVN
Microsoft cut ~3,200 Xbox jobs (“our business today is not healthy”) — margin discipline funding the AI build. Fiserv (−70% y/y) has four banks circling its STAR/Accel network. Toyota spends $3.6B to reshore the Tacoma to Texas after an $8.5B tariff hit. Delta/United at records with fares up 8 times since the war while fuel fell 40% — consolidation pricing. Shell’s traders guided significantly higher on war volatility. Rivian −18% on a $1.5B share sale plus an ASP warning.
⛔ AVOID
MSTR · gated/evergreen private wrappers
Strategy sold 3,588 BTC ($216M) after “never sell,” authorized $1.25B more, and raised its STRC preferred to 12% with ~17 months of cash buffer — a yield that liquidates its own thesis. Private equity sits on 13,500 unsold companies (~9 years to clear; ~1,500 held 9+ years) — when the exit is a waiting list, the “income” is a promise. Public bids only for retirement income.
4.5% Uniform Bonds + Completeness — May 15, 2026
Every Aggressive tier (both A and B variants — 8 panels total) now carries an identical 4.5% bond sleeve: TIP 1.5% + SGOV 1.5% + IEF 1.5%. All four A-variant tabs (50k-core, 100k-core, 250k-core, 500k-core) now sum to exactly 99.50% with 4.5% bonds + 0.5% SGOV settlement buffer + 95.0% equity. B-variant tabs received matching bond-row inserts and theme-block updates. portfolios.html B-tab panels replaced with the canonical portfolios-models.html versions so both files now show identical Aggressive holdings.
Action
Change
Rationale
📊 REBALANCE
Uniform 4.5% bond sleeve across all 8 Aggressive tabs
TIP 1.5% + SGOV 1.5% + IEF 1.5% = 4.5% per tier, identical recipe across Tier I–IV in both A (Tactical Conviction) and B (Fundamentals Core) variants. Replaces the previous mixed-state where some tiers had 0%, 4%, or 5% bonds. Inflation hedge (TIP), liquidity / settlement (SGOV), and duration (IEF) each get 1.5% — balanced three-leg sleeve per CFP IN09.
✂️ TRIMS
Tier I-A & Tier II-A — 4.5% pulled from Mag7 leaders
NVDA 4.75→4.25, MSFT 4.75→4.25, AAPL 4.50→3.75, GOOGL 4.50→3.75, AMZN 4.00→3.25, META 4.00→3.25, AVGO 4.50→4.00. Total trim = 4.50%. All names kept; weights still respect 5% single-stock cap.
✂️ TRIMS
Tier III-A / IV-A — proportional Mag7 trims
Tier III-A pulled 0.50%–0.75% from NVDA / MSFT / AAPL / GOOGL / AMZN / META / AVGO (total 4.50%). Tier IV-A applied same recipe scaled to its smaller existing Mag7 weights. No positions dropped.
✂️ TRIMS
Tier I-B (tab-50k) — bond sleeve added from zero
tab-50k previously carried 0% bonds. Added TIP + SGOV + IEF rows at 1.5% each; freed 4.5% by trimming NVDA 2.81→2.31, AVGO 2.81→2.31, AAPL/MSFT/GOOGL/AMZN/META/TSLA 2.50→2.00 each, and PLTR 3.38→2.88. Same positions retained, 4.5% bond sleeve added.
Tier III-B (tab-250k) & Tier IV-B (tab-500k) — oversize bond legs trimmed
tab-250k IEF 2.0→1.5 (0.50% redeployed to NVDA). tab-500k TIP 2.0→1.5 (0.50% redeployed to NVDA). Bond composition now identical across all 8 tabs: TIP 1.5 + SGOV 1.5 + IEF 1.5.
📚 CANONICAL
portfolios-models.html confirmed as canonical complete page
Completeness audit: every port-panel in portfolios.html exists in portfolios-models.html (22 panels). portfolios-models.html additionally carries tab-div5, tab-taxefficient, tab-techquantum which are not on portfolios.html — consistent with portfolios-models.html being the canonical complete model book. Zero panels need propagation from portfolios.html to portfolios-models.html.
portfolios.html had divergent legacy Aggressive B-tab content (overweight to 130–140% with 0% bonds). The 8 Aggressive tabs in portfolios.html now mirror their portfolios-models.html counterparts so the portal’s default sync URL and the public models page agree exactly.
A/B Methodology Reframe — May 15, 2026
Aggressive tier A/B tabs renamed to make sourcing methodology obvious. A = Tactical Conviction (daily news-driven). B = Fundamentals Core (CFP earnings-driven). Each Aggressive tier ($50K through $500K) now has both. Tactical books also propagated to portfolios.html so the portal’s default sync URL captures them.
Action
Change
Rationale
⚙️ FRAMING
Tier X-A renamed to Tactical Conviction
All four A-tier tabs renamed from “Concentrated 27 / 30 / 35” to “Tactical Conviction (Daily News-Driven).” These books are sourced from daily market commentary — earnings beats, geopolitical news, sector rotations, M&A — with 3–18 month conviction horizons. Position counts unchanged (27/27/30/35). Math intact at 99.50% per tier.
⚙️ FRAMING
Tier X-B renamed to Fundamentals Core
All four B-tier tabs renamed from “Diversified High Conviction” to “Fundamentals Core (CFP Earnings-Driven).” These books are sourced from CFP-grounded earnings, balance-sheet, and secular-thesis analysis, with 3–10 year conviction horizons. Position counts unchanged (~75 / 37 / 54 / 68).
🔗 PORTAL
Tactical Conviction panels added to portfolios.html
Client portal’s “Sync from Website” default URL fetches portfolios.html. Added the 4 -core port-panels (tab-50k-core, tab-100k-core, tab-250k-core, tab-500k-core) to the hidden scaffolding mirror so the portal parser sees them without the user editing the sync dialog. Existing B-tier titles in portfolios.html also renamed to Fundamentals Core.
📚 DOCS
Methodology page updated
Added “Our two-track sourcing methodology” section to portfolio-audit.html explaining how Tactical Conviction (A) and Fundamentals Core (B) differ on sourcing methodology, not breadth. A sleeves are faster-moving (3–18mo); B sleeves are slow-compounding (3–10yr).
Tier II/III/IV Concentrated -A Tabs Added — May 15, 2026
Three new Concentrated tabs added: Tier II-A (27 names, $100K), Tier III-A (30 names, $250K), Tier IV-A (35 names, $500K). Each sums to 99.5% and stays under the 5% single-stock cap. Portal-synced via slugs aggressive_100k_concentrated, aggressive_250k_concentrated, aggressive_500k_concentrated.
Action
Change
Rationale
🏗️ STRUCTURE
Tier II-A — Concentrated 27 ($100K)
New tab-100k-core mirrors the Tier I-A roster and weights at the $100K AUM tier. Same CFP IN09 / Statman sweet spot of 25–30 names. Portal-synced via slug aggressive_100k_concentrated. Single-stock cap respected (max 4.75%). Sums to 99.50% exactly (27 names + 0.5% SGOV settlement buffer).
🏗️ STRUCTURE
Tier III-A — Concentrated 30 ($250K)
New tab-250k-core extends the Tier I-A roster with three sector-breadth additions: ANET (AI networking), HCA (hospital systems), SLB (energy services). Still within CFP IN09's 25–30 concentrated sweet spot. Portal-synced via slug aggressive_250k_concentrated. Single-stock cap respected (max 4.25%). Sums to 99.50% exactly.
🏗️ STRUCTURE
Tier IV-A — Concentrated 35 ($500K)
New tab-500k-core extends Tier III-A with five more diversifiers: NEM (gold mining), ABBV (immunology), DE (industrials / ag), V (payments), KO (defensive staple). Upper edge of concentrated per CFP IN09 (25–35 names). Portal-synced via slug aggressive_500k_concentrated. Single-stock cap respected (max 4.00%). Sums to 99.50% exactly.
🔢 FRAMEWORK
Progressive-breadth Concentrated ladder
The four -A tabs (I-A, II-A, III-A, IV-A) now form a progressive-breadth Concentrated ladder: $50K and $100K share the 27-name roster; $250K adds 3 names for breadth; $500K adds 5 more for full sector coverage while staying inside the CFP IN09 concentrated band. Each tier remains 100% equity by design with a 0.5% SGOV settlement buffer.
Halal AAOIFI Re-Screen — May 15, 2026
Halal model re-screened to AAOIFI standards. BAC and ABNRY removed (conventional banks fail riba screen). SFTBY removed (fails debt-to-assets leverage screen). TSM, AMKR, NEM retained (Sharia-eligible). Halal book rebalanced to exactly 99.5% with HLAL 6% anchor and 0.5% cash reserve preserved.
Action
Change
Rationale
❌ SCREEN
BAC, ABNRY confirmed out of Halal
AAOIFI riba screen: conventional banks are excluded from any Sharia-compliant book. Same reason JPM was previously removed. Confirmed zero presence in tab-halal after the May 14 daily-news pass — re-screen QA verifies clean.
❌ SCREEN
SFTBY confirmed out of Halal
AAOIFI debt-to-assets leverage screen fails (>33% threshold). Confirmed zero presence in tab-halal after the May 14 daily-news pass.
✅ RETAIN
TSM, AMKR, NEM kept (Sharia-eligible)
TSM (semis, low debt), AMKR (semi packaging, non-financial), NEM (gold mining) clear the AAOIFI screen. Retained at Halal-appropriate weights: TSM 2.00%, AMKR 1.50%, NEM 1.50%.
📊 REBALANCE
Halal book brought from 108.80% → 99.50%
The May 13 + May 14 conviction adds had not been retrimmed; visible sum was 108.80%. Surgical correction trims TPL/XOM/CVX/COP/PLTR/IAU by 1.00% each, TSM by 1.00%, AMKR by 0.30%, DE by 0.50%, and removes the duplicate BA row (1.50%). NVDA 4.00%, AVGO 3.50%, CRWD 1.50%, HLAL 6.00% anchor, and Cash 0.50% all preserved unchanged.
Model Framing Standardization — May 15, 2026
Every model card on portfolios-models.html now carries consistent thesis + IPS + Tax Location + Effective Theme Exposure callouts. Naming standardized to “Diversified High Conviction” where the model character fits; adapted to “Concentrated High Conviction” for Tech & Quantum and “Passive Diversified Allocation” for 403(b) Vanguard Passive.
Action
Change
Rationale
🔢 FRAMEWORK
Standardized four-block disclosure on every model
Every model card now opens with a thesis intro, then surfaces three matched callouts: Investment Policy Statement (six lines — risk band / time horizon / liquidity / return objective / rebalancing / excluded screens), Tax Location Guidance (best fit / acceptable / avoid), and Effective Theme Exposure summing to 99.5% with an explicit 0.5% Cash / Operational Reserve row. The six CFP-audit tiers already carried these blocks; the seven additional models (Dividend & Income, Balanced 5% Dividend, Tax-Efficient, Tech & Quantum, 403(b) Vanguard Passive, 403(b) CWLG Custom, Orion 403(b)) now carry them too.
🔢 NAMING
“Diversified High Conviction” framing where the model character fits
Aggressive Tiers I-B / II-B / III-B / IV-B now read as “Diversified High Conviction” alongside Tier I-A “Concentrated 27”. Dividend & Income, Balanced 5% Dividend, Halal, Tax-Efficient, 403(b) CWLG Custom, and Orion 403(b) all carry the same “Diversified High Conviction” suffix. Tech & Quantum is renamed “Concentrated High Conviction (Speculative Theme)” to honor the position-count discipline. 403(b) Vanguard Passive is renamed “Passive Diversified Allocation (Vanguard SB1)” to avoid misrepresenting passive index sleeves as active conviction.
🔢 FRAMEWORK
Names updated everywhere they appear
Dropdown / model picker labels, model-card titles in the strategies grid, and the port-title headings on every panel were all updated in one pass so the picker, the page heading, and the panel title agree. No holdings, weights, or YTD values were touched — pure framing / copy work.
Tier I Split — May 15, 2026
Structural change to the Aggressive Tier I model. The book now splits into two independently portal-synced sleeves: Tier I-A (True Concentrated, 27 names sized 2.5–4.75% per CFP IN09 sweet spot) and Tier I-B (Diversified High-Conviction, ~75 names across 12 themes — the existing roster, preserved). Full methodology: How We Optimize — A Quarterly CFP-Grounded Review.
Action
Change
Rationale
🏗️ STRUCTURE
Tier I split into two tabs
The new tab-50k-core (Tier I-A: True Concentrated, 27 names) sits alongside the existing tab-50k (Tier I-B: Diversified High-Conviction, ~75 names). Portal-synced via slugs aggressive_50k_concentrated and aggressive_50k respectively. Tier I-A is the conviction-tight book sized 2.5–4.75% per name; Tier I-B preserves the broader theme-coverage book for clients who want the long tail.
🔢 FRAMEWORK
CFP IN09 sweet spot at 25–30 names
Tier I-A lands at the diversification-benefit plateau identified in CFP IN09 (Statman). Beyond ~30 names the marginal risk-reduction from another position is overwhelmed by friction and dilution. The new Concentrated sleeve makes that thesis explicit; the Diversified sleeve serves clients who want broader theme breadth.
🔢 FRAMEWORK
Independent portal slugs
Each sleeve maintains its own portal-sync slug, so client portfolio proposals can reference either Tier I-A or Tier I-B as the linked model without ambiguity. The previous self-contradiction (card claimed “22 positions” while the underlying table held ~75 rows) is now resolved on both sides.
CFP Audit Optimizations — May 12, 2026
Quarterly CFP-grounded review applied across the model book. Strengthens Sharia screen on the Halal model, adds a right-sized 4-5% bond sleeve (TIP + SGOV + IEF) to Aggressive Tiers II/III/IV, broadens international diversification to 16-23% via 8 individual international names (ASML, NVO, SAP, TM, EWY, PBR, IBN, CPNG) across diversified tiers, adds a 0.5% cash buffer per tier for settlement reserve, and codifies Investment Policy Statement + tax-location guidance on every model card. Full methodology: How We Optimize — A Quarterly CFP-Grounded Review.
Action
Change
Rationale
🆕 ADD
HLAL 6% in Halal model
Strengthens the Sharia screen with a diversified compliant US equity ETF (Wahed FTSE USA Shariah). Consolidates prior smaller Sharia-ETF positions into a single anchor. Halal model now totals 100% with AAOIFI screening disclosed.
🆕 ADD
8 individual international names across Aggressive Tiers
Adds 16-23% international diversification across Aggressive Tiers II / III / IV via 8 hand-picked international names (ASML, NVO, SAP, TM, EWY, PBR, IBN, CPNG) per CFP IN09 (Asset Allocation & Diversification). No passive ETF base — every position is a conviction call spanning developed Europe (ASML, NVO, SAP), Japan (TM), Korea (EWY proxy for Samsung-heavy exposure + CPNG for e-commerce), Brazil (PBR), and India (IBN). Funded jointly from a halved bond sleeve and from staples / low-conviction equity trims; defense, energy, and Mag7-core theses preserved.
🆕 ADD
4-5% bond sleeve (TIP + SGOV + IEF) in Tiers II / III / IV
Right-sized bond sleeve halved from the prior 8-10% target after client review — correlation-diversifier + rebalancing-source benefit is preserved at the 4-5% level while freed weight goes to broader international (8 international names (ASML, NVO, SAP, TM, EWY, PBR, IBN, CPNG)). Tier II: 4% (1.5 TIP + 1.5 SGOV + 1.0 IEF). Tier III: 5% (1.5 / 1.5 / 2.0). Tier IV: 5% (2.0 / 1.5 / 1.5). Tier I remains 100% equity by design.
🆕 ADD
0.5% cash buffer per tier (SGOV settlement reserve)
Every model carries an explicit 0.5% Cash / Operational Reserve row (SGOV-style settlement buffer) so each tier sums to 99.5% on the prescribed-weight side, with the 0.5% buffer absorbing settlement timing, dividend reinvestment lag, and rebalancing friction. AAOIFI-permitted on the Halal model.
🔢 FRAMEWORK
Investment Policy Statement on every model card
Six-line IPS block added to each model — risk band, time horizon, liquidity, return objective, rebalancing trigger, and excluded screens. Codifies CFP IN07 / IN08 best practice.
🔢 FRAMEWORK
Tax Location Guidance on every model card
Best-fit / Acceptable / Avoid-for-high-bracket account-type guidance now displayed. Aggressive tiers lean Roth; income tiers acceptable in taxable with qualified-dividend rate; Halal screen is portable across account types.
🔢 FRAMEWORK
Effective Theme Exposure disclosure
Net theme exposure now shown on each model card (e.g. AI/Tech, Defense, Energy, International, Bonds/Cash). Honest disclosure that nets across sector labels rather than hiding overlap in granular sector codes.
🔹 TRIM
Tier I Defense (smaller-cap names)
Tier I concentrated tier holds defense as a multi-year structural rearmament thesis. Smaller-cap names sized closer to 2% each to keep single-sector exposure under 22% per CFP IN09 concentrated-portfolio guidance. Core LMT / NOC / RTX / GD weighting preserved.
🔹 CLEANUP
Floating-point display fix
Decimal-precision artifact (0.21250000000000002%) rounded to two decimals across the Dividend Yield Focus model. Cosmetic / display only.
CFP-Grounded Methodology
Reviews the framework we use to construct and maintain every model — concentration limits, diversification standards, tax-location, rebalancing triggers, and values-based screens.
May 9 ADDs: INTC, HCA, COST. REINFORCE: AAPL, UNH, WMT, SONY. REDUCE: TSM (-50bps), WEN. WATCH: TM, LMT, NOC, MCD, Siemens, Schneider. THESIS: April payrolls +115K beat 55K est; Apple-Intel preliminary chip-foundry deal validates U.S. semis revival; Russia-Ukraine 3-day Victory Day truce; Sony double-digit FY guide vs Wendy's -7.8% SSS = LIFT Tech (Apple/Intel pair-trade) and Healthcare (HCA/UNH) on jobs strength; TRIM Taiwan-Strait single-foundry concentration via TSM -50bps; AVOID mid-tier QSR (Wendy's) as traffic flows to McDonald's value menu.
Action
Position
Rationale
🆕 ADD
INTC (Intel)
Preliminary Apple foundry deal validates Intel Foundry as a credible TSM alternative. CHIPS Act + 10% U.S. government stake support thesis. New CEO Lip-Bu Tan turning the ship. 1.5% in $250K, 2.0% in $500K.
🆕 ADD
HCA (HCA Healthcare)
April jobs report shows healthcare leading hiring; structural demographic tailwind. Largest U.S. for-profit hospital operator. 1.0% in $250K, 1.5% in $500K.
🆕 ADD
COST (Costco)
Trade-down dynamic + jobs strength favors club retail; resilient membership model. 1.5% in $250K.
⬆️ REINFORCE
AAPL (Apple)
Chip supply diversification de-risks Taiwan tail; Intel pact reduces single-foundry exposure. Add to existing core position across all tiers.
Value-trading consumer benefits Walmart at expense of mid-tier QSR like Wendy's. Existing position lifted in $250K and $500K.
⬆️ REINFORCE
SONY (Sony)
Double-digit FY earnings guide; PlayStation/music/pictures cash flows durable across cycle. 1.0% added in $500K.
🔹 REDUCE
TSM (Taiwan Semiconductor)
Foundry concentration risk; trim 50 bps but keep core position — still the leader. Reduce in $500K aggressive.
🔹 REDUCE
WEN (Wendy's)
Q1 U.S. same-restaurant sales -7.8%; traffic going to McDonald's value menus. Chart broken; no near-term catalyst. Exit watchlist; outright reduce.
👀 WATCH
TM (Toyota)
Profit beat but FY guidance warned on Iran war drag. Stock cheap; wait for next print before adding.
👀 WATCH
LMT, NOC, RTX (Defense Primes)
3-day Russia/Ukraine truce small signal; structural rearmament thesis intact. Don't add on truce headlines, don't trim either.
👀 WATCH
MCD (McDonald's)
Going back to value menus; benefits at Wendy's expense. Existing position fine.
👀 WATCH
Siemens (SIE), Schneider Electric (SU)
European industrials catch a tailwind from any real Ukraine settlement — reconstruction beneficiaries. Position lightly while framework uncertain.
🎯 THESIS
Apple-Intel pair-trade
Long INTC + AAPL, short or trim TSM. The chip-supply diversification trade is the cleanest investable expression of Taiwan-Strait risk reduction. Sized small to start; room to add as Apple-Intel chip families get specified publicly.
🎯 THESIS
Jobs-strength healthcare LIFT
April +115K payrolls beat with healthcare leading. Demographic tailwind structural. HCA/UNH overweighted; CVS held; NVO watched.
🎯 THESIS
Premium-vs-value consumer split
Sony double-digit guide and Costco strength on the premium side; Wendy's -7.8% on the value side. Own both ends, avoid the squeezed middle.
Want the full holdings book?
The watchlist is what we're building toward. The model portfolios are where everything currently sits, with target weights, sector breakdowns, and live rate-of-return cards.